On the dermatological aspects of the novel coronavirus infection (COVID-19)

DOI: https://dx.doi.org/10.18565/pharmateca.2021.8.42-47

I.V. Kosheleva (1, 3), O.A. Bitkina (2), L.I. Shadyzheva (1), O.V. Andriyakhina (3), A.Yu. Nikolaeva (2), M.N. Fyrnina (2), M.A. Deryavaya (2), K.S. Pershina (2), D.S. Zueva (2), A.A. Tsyganova (2)

1) Russian Medical Academy of Continuous Professional Education, Moscow; 2) Privolzhsky Research Medical University, Nizhny Novgorod; 3) “RZD-ZDOROVIE”, Moscow
The review continues the topic of describing the types of skin rashes associated with the novel coronavirus infection (COVID-19), including against the background of drug treatment, supplementing the information given in the previous publication of the same authors (Farmateka. 2020;27(8):8–17). The article also describes some of the features of the cutaneous manifestations of post-COVID-19 syndrome and presents authors’ own observations of 27 cases of reactive diffuse alopecia that developed after COVID-19. Information on some of the indirect dermatological problems of patients and medical personnel, on the features of the provision of dermatological care and training of dermatologists associated with the COVID-19 pandemic is provided.

About the Autors

Corresponding author: Oksana A. Bitkina, Dr. Sci. (Med.), Professor at the Department of Skin and Venereal Diseases, Privolzhsky Research Medical University, Nizhny Novgorod, Russia; oksana381@yandex.ru
Address: 10/1 Minin and Pozharsky Square, Nizhny Novgorod 603006, Russian Federation

Similar Articles

Бионика Медиа